To address the utility of intensive glycemic control in patients with poorly controlled diabetes and gastroparesis, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Gastroparesis Clinical Research Consortium (GpCRC) conducted the Pilot Study of the Safety, Feasibility, and Potential Efficacy of Continuous GLUcose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG). Here, INS is linked to kidney disorder.